Transcription patterns of human papillomavirus type 16 in genital intraepithelial neoplasia: evidence for promoter usage within the E7 open reading frame during epithelial differentiation
Human papillomavirus (HPV) type 16 transcription was analysed by in situ hybridization using 125I-labelled subgenomic riboprobes, from 26 genital intraepithelial neoplastic (IN) lesions, in formalin-fixed biopsies from 18 different cases. Distinct transcription patterns separable by the presence or absence of late gene transcription were detected. In 12 lesions, late gene expression was absent; HPV transcripts corresponding to the E6 and E7 open reading frame (ORF) were detectable in all basal cells and were usually evenly distributed through all layers of the epithelium. Transcripts corresponding to the E1, E2 and E2/E4 ORFs were present in nine of 12 lesions and displayed a similar distribution. In 14 lesions late gene transcripts were present. E6 and E7 transcripts were detectable basally in all but one lesion. The levels of E7 but not E6 transcripts were markedly increased in the superficial cells of differentiating epithelia, with an identical distribution and at similar levels to those of the E2/E4 transcript. We propose that the most abundant transcript in genital IN lesions containing late gene expression is an E7/E1 ^ E2/E4 transcript corresponding to that reported in HPV-6/11 condylomata and which is derived from a similar promoter within the E7 ORF.
AndersonL. J.,
TsouC.,
ParkerR. A.,
ChorbaT. L.,
WulffH.,
TattersallP.,
MortimerP. P.1986; Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 24:522–526
AndersonM. J.,
JonesS. E.,
MinsonA. C.1985; Diagnosis of human parvovirus infection by dot-blot hybridisation using cloned viral DNA. Journal of Medical Virology 15:163–172
BrownC. S.,
SalimansM. M. M.,
NotebornM. H. M.,
WeilandH. T.1990; Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system. Virus Research 15:197–211
CohenB. J.,
MortimerP. P.,
PereiraM. S.1983; Diagnostic assays with monoclonal antibodies for the human serum parvoviruslike virus (SPLV). Journal of Hygiene 91:113–130
KajigayaS.,
ShimadaT.,
FujitaS.,
YoungN. S.1989; A genetically engineered cell line that produced empty capsids of B19 (human) parvovirus. Proceedings of the National Academy of Sciences, U.S.A 86:7601–7605
KajigayaS.,
FujiiH.,
FieldA.,
AndersonS.,
RosenfieldS.,
AndersonL. J.,
ShimadaT.,
YoungN. S.1991; Self assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunologically similar to native virus. Proceedings of the National Academy of Sciences, U.S.A 88:4646–4650
MortimerP. P.,
HumphriesR. K.,
MooreJ. G.,
PurcellR. H.,
YoungN. S.1983; A human parvovirus-like virus inhibits haematopoietic colony formation in vitro
. Nature, London 302:426–429
SatoH.,
HirataJ.,
FurukawaM.,
KurodaN.,
ShirakiH.,
MaedaY.,
OkochiK.1991; Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19. Journal of Virology 65:1667–1672
YoshimotoK.,
RosenfeldS.,
FrickhofenN.,
KennedyD.,
HillsR.,
KajigayaS.,
YoungN. S.1991; A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response. Journal of Virology 65:7056–7060
Transcription patterns of human papillomavirus type 16 in genital intraepithelial neoplasia: evidence for promoter usage within the E7 open reading frame during epithelial differentiation